Pacgen Life Science (CVE:PBS) Sets New 52-Week Low at $0.02

Pacgen Life Science Corp (CVE:PBS)’s share price reached a new 52-week low on Monday . The company traded as low as C$0.02 and last traded at C$0.02, with a volume of 5000 shares changing hands. The stock had previously closed at C$0.02.

The firm has a market capitalization of $1.05 million and a PE ratio of -5.00. The company’s 50 day simple moving average is C$0.02.

About Pacgen Life Science (CVE:PBS)

Pacgen Life Science Corporation, a life sciences company, focuses on building a commercial platform to market and distribute consumer health products in North America. It markets its oral and skin care products under the P113+, DermaMed, DermaSoleil, and Deserving Health brand names. The company was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in May 2012.

Featured Story: What is the Moving Average Convergence Divergence (MACD) oscillator?

Receive News & Ratings for Pacgen Life Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pacgen Life Science and related companies with MarketBeat.com's FREE daily email newsletter.